Assay of Adhesion Under Shear Stress for the Study of T Lymphocyte-Adhesion Molecule Interactions

Podsumowanie

This flow adhesion assay provides a simple, high impact model of T cell-epithelial cell interactions. A syringe pump is used to generate shear stress, and confocal microscopy captures images for quantification. The goal of these studies is to effectively quantify T cell adhesion using flow conditions.

Streszczenie

Overall, T cell adhesion is a critical component of function, contributing to the distinct processes of cellular recruitment to sites of inflammation and interaction with antigen presenting cells (APC) in the formation of immunological synapses. These two contexts of T cell adhesion differ in that T cell-APC interactions can be considered static, while T cell-blood vessel interactions are challenged by the shear stress generated by circulation itself. T cell-APC interactions are classified as static in that the two cellular partners are static relative to each other. Usually, this interaction occurs within the lymph nodes. As a T cell interacts with the blood vessel wall, the cells arrest and must resist the generated shear stress.^1,2 These differences highlight the need to better understand static adhesion and adhesion under flow conditions as two distinct regulatory processes. The regulation of T cell adhesion can be most succinctly described as controlling the affinity state of integrin molecules expressed on the cell surface, and thereby regulating the interaction of integrins with the adhesion molecule ligands expressed on the surface of the interacting cell. Our current understanding of the regulation of integrin affinity states comes from often simplistic in vitro model systems. The assay of adhesion using flow conditions described here allows for the visualization and accurate quantification of T cell-epithelial cell interactions in real time following a stimulus. An adhesion under flow assay can be applied to studies of adhesion signaling within T cells following treatment with inhibitory or stimulatory substances. Additionally, this assay can be expanded beyond T cell signaling to any adhesive leukocyte population and any integrin-adhesion molecule pair.

Wprowadzenie

T lymphocyte adhesion mediates a number of distinct processes in a healthy immune system,³ playing critical roles in T cell trafficking and antigen presentation. Whether during immune surveillance or an active immune response these two broad roles for adhesion are critical.⁴ The physiological signaling events of T cell-endothelial cell interactions are distinct from T cell-antigen presenting cell (APC) interactions, and therefore require distinct methods of study to best understand the signaling cascades involved. The firm adhesion of a T cell to a blood vessel wall during lymphocyte extravasation requires rapid and dynamic integrin activation. The tight interaction between an active state integrin and adhesion molecules along the endothelium leads to adhesion resistant to the flow of blood, allowing T cells to crawl along the surface in search of an area permissive to cell passage.⁵ The crawling of a T cell bi-directionally along a blood vessel wall is reliant upon polarized adhesion, with a distinct adhesive front end of the T cell.⁶ Most importantly, firm adhesion and transmigration require resistance to the shear force generated by circulating blood flow.

When designing experiments to study lymphocyte adhesion, attention should be paid to the specific stimulus of interest. While integrin activation is a common and critical component of all forms of T cell adhesion, the cascades of activation are likely to be unique downstream of individual receptors and co-receptors. Likewise, integrin and adhesion molecule pairs function in specialized microenvironments and on specific subpopulations. In this way, these pairs may be regulated quite differently. The model presented here is ideal for the study of signaling cascades leading to integrin activation taking place under shear stress conditions.⁷ These interactions cannot be adequately understood in a static adhesion system due to the impact these forces have been shown to have directly on T cell behavior.⁸ Though presented here with T cells and CHO (Chinese Hamster Ovary) cells engineered to express human ICAM-1 (CHO-ICAM cells) the system can easily be modified to study different leukocyte populations or adhesion molecules.

This assay provides a method to quantify T cell adhesiveness and integrin activation using shear stress, providing a model for the firm adhesion stage of leukocyte extravasation. Through the use of CHO-ICAM cells the affinity of LFA-1 for its ligand in live cells can be examined in real time in response to various stimuli of interest. This technique requires easily obtained, commercially available micro-flow chambers in combination with a syringe pump, greatly simplifying the equipment necessary to model blood flow and shear stress as compared to other models.⁹ Another major advantage of this assay is that specific signaling cascades and the resulting activation state of individual integrins can be cleanly studied through the use of engineered CHO cells expressing human adhesion molecules of interest. Additionally, the combination of quantitative data with live cell imaging is a significant advantage of this method. Overall, while a number of assays of static T cell adhesion have been described that nicely model T cell-APC interactions, these models are insufficient in capturing the dynamic process of T cell-epithelial adhesion. For this reason, when choosing an adhesion assay the stimulus in question must be considered.

Protokół

1. Plating the CHO-ICAM Cells

Note: The goal of this step is to plate the CHO-ICAM cells in the flow chambers for growth overnight with the goal of generating a confluent monolayer.

1. Maintain CHO-ICAM cells in 10 cm tissue-culture treated culture dishes in 10 ml RPMI media supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (CHO-ICAM complete culture media) at 37 °C with 5% CO₂.
2. To collect cells, add 1 ml 0.5% trypsin-EDTA and incubate at room temperature for 1 min with gentle shaking. Neutralize the trypsin with 4 ml of media.
3. Count the CHO-ICAM cells using a hemacytometer and calculate 0.75 x 10⁵ cells per chamber. Note: In this experiment: 2.25 x 10⁵ cells will be needed to seed 3 chambers.
4. Centrifuge 0.75 x 10⁵ CHO-ICAM cells per chamber for 5 min at 500 x g, room temperature and resuspend the cell pellet in 30 µl per chamber of CHO-ICAM complete culture media.
   Note: In this experiment 90 µl will be needed to seed 3 chambers.
5. Slowly add the cells into one reservoir of the flow chamber. Allow the cells to settle for 5 min in the 37 °C incubator with 5% CO₂.
6. Add 200 µl of complete culture media across the two reservoirs of each chamber. Alternate additions between the two to avoid movement of the cells as the system equilibrates.
7. Incubate the cells overnight inside a 37 °C incubator with 5% CO₂.

2. Preparation of the T Cells

Note: This assay can be done with primary human T cells or a T cell line. A protocol on T cell isolation from blood has been described previously.¹⁰ If using primary human T cells use freshly isolated cells for best results. If using a T cell line, follow the culture protocol specified by the source of the cells. In order to detect the cells on a fluorescent microscope the T cells are labeled with carboxy fluorescein succinimidyl ester (CFSE).

1. Count the T cells using a hemacytometer and calculate 2 x 10⁶ cells per chamber. Note: In this experiment, 6 x 10⁶ cells will be needed for 3 chambers.
2. Centrifuge 2 x 10⁶ T cells per chamber for 5 min at 500 x g, room temperature and resuspend the cells in 1 ml of phosphate buffered saline (PBS) containing 1% glucose or 2% FBS.
3. Add CFSE at 1:1,000 dilution (stock made to 5 mM). Cover from light and incubate for 8 min at RT
4. Spin at 500 x g for 5 min, RT.
5. Resuspend cell pellet with 240 µl per condition (See Section 4 "Note") of RPMI media lacking serum. In this experiment, resuspend the cell pellet in 720 µl of plain RPMI. Divide the cells into empty 1.5 ml tubes labeled for each chamber, 240 µl per tube. Keep cells in a 37 °C heat block until use.

3. Setting up the Input/Output Hosing and Syringe Pump

1. Warm the microscope live imaging chamber to 37 °C.
2. Prepare the input hosing:
   1. Fill a 500 ml glass bottle with water and make 2 holes into the lid. Label the holes "in" and "out." This will act as a heating water bath for the input media.
   2. Run the input hosing through the holes in the lid and into the water bath. Ensure that the side of the hosing that connects to the syringe comes through the "in" hole and the side that will connect to the input reservoir comes through the "out" hole.
   3. Flush the input hosing with 60 ml of water to remove any air from the system.
   4. Prime the input hosing with RPMI media lacking serum warmed to 37 °C. Fill a 60 ml syringe and push through the media until the hosing is completely primed and lacking any air bubbles.
      Note: Depending on the length of tubing used the volume required to prime will vary.
      1. Calculate the volume of media needed for the experiment by multiplying the rate of flow (here 0.3 ml/min) by the number of minutes (5 min) by the number of chambers in the experiment (here 3); in this experiment, use 4.5 ml media. Note: We recommend having 5 ml extra volume (here totaling 9.5 ml) remaining in the syringe after priming.
   5. Place the entire input setup into the live imaging enclosure of the microscope to maintain 37 °C. Run the hosing and syringe out of the enclosure and load the syringe into the syringe pump.
3. Prepare the output hosing:
   1. Make a hole in the lid of a 250 ml bottle to use as output waste.
   2. Run the output tubing through the hole and into the bottle. Loosely secure the lid, not closing all the way.
   3. Place the output setup into the live imaging enclosure of the microscope.
4. Calculate the flow rate (ml/min) necessary to generate the desired shear stress (dyn/cm²). Shear stress varies in different vascular compartments, therefore take into account the overall model including cell types to be studied and treatments when deciding on a shear stress level.
   Note: These experiments are conducted at 0.4 dyn/cm² to closely mimic a small vein setting.
   1. Take the chamber dimensions into account when calculating shear stress. Use the following formula (provided by the manufacturer¹¹) for the flow chambers used here (See Table of Materials): T = η * 176.1 * ø where T = shear stress, η = dynamical viscosity, ø = flow rate. Note: The dynamical viscosity of RPMI media at 37 °C is 0.007.

4. Loading of the Flow Chambers and Stimulation of the Cells

Note: In order to initiate adhesion, T cells must be stimulated. In the following experiment the cells will either remain unstimulated or are stimulated with SDF-1α¹² or phorbol myristate acetate (PMA; positive control)¹³. For proper presentation of chemokine to T cell, CHO-ICAM cells are preincubated with SDF-1α (followed by serial washes), allowing for presentation on the cell surface. PMA is a phorbol ester that is structurally similar to the second messenger diacyl glycerol (DAG); here it is used as a positive control. T cells are directly treated with PMA prior to loading into the flow chamber.

1. Place the flow chamber slide on the microscope and set the focal plane on the CHO-ICAM monolayer using the 20X objective.
2. Keep CFSE-stained T cells for all other conditions in the 37 °C heat block. Prepare the CHO-ICAM or T cells as follows immediately prior to the assay for that condition:
   1. For the unstimulated condition (chamber 1), keep one tube/flow chamber untreated, to serve as negative control for stimulation.
   2. For PMA stimulation (chamber 2), stimulate one tube of T cells with PMA (10 ng/ml) to serve as positive control; treat immediately before loading into flow chamber.
   3. For SDF-1α stimulation, (chamber 3), stimulate the third flow chamber with SDF-1α (100 ng/ml) by removing 70 µl at a time 3 times from the upper reservoir (output reservoir) and then adding 70 µl of SDF-1α (100 ng/ml) into the lower reservoir (input reservoir). Incubate for 5 min.
3. Remove and discard 70 µl at a time 3 times from the output reservoir of one chamber.
4. Add 70 µl of pre-treated (as applicable) T cell suspension into the input reservoir 3 times. Wait 5 min to allow the cells to move from the inlet of the chamber ("In"), and to reach the proximal outlet ("Out") of the chamber.
5. During this time, image 5 fields for CFSE-stained T cells. Choose fields that are dispersed throughout the center of the chamber (Figure 1). Use the following excitation/emission conditions: excitation laser wavelength: 488 nm; emission collection filter: 500 - 540 nm. These images will serve as the pre-flow cell counts.
6. Attach the input and output tubing simultaneously to the flow chamber reservoirs.
   Note: Attaching the tubing simultaneously is critical so as to not introduce air bubbles into the chamber and maintaining overall equilibrium within the chamber.
7. Begin flow at 0.3 ml/min (0.4 dyn/cm²) while visualizing the CFSE-stained T cells. As flow begins, especially with the first chamber, there is often a lag between initiating flow and observing T cell rolling, therefore begin timing 5 min at the onset of T cell movement.
8. Terminate flow after 5 min, and image 5 fields in the CFSE channel. Choose fields randomly dispersed throughout the center of the flow chamber (Figure 1). These images will serve as the post-flow cell counts.

5. Determining the Percentage of Adherent Cells

Note: Determination of the number of the cells in the acquired images is done objectively with automated software. For our studies we used the software Volocity (Version 6.2.1), but other software such as ImageJ (Version 1.48V) are also applicable.

1. Determine the number of cells per field pre-flow for each condition. The average of the 5 fields is the "pre-flow average cell count." ⁷
2. Determine the number of cells per field post-flow for each condition. The average of the 5 fields is the "post-flow average cell count."⁷
3. Calculate the percentage of adherent cells using the following formula: Percentage of adherent cells = (post-flow average cell count)/(pre-flow average cell count) x 100%.

Wyniki

Representative results are shown from the flow adhesion assay using Jurkat and primary human CD3⁺ T cells, as indicated, stimulated with SDF-1α. The negative controls in all shown experiments are unstimulated cells. A threshold basal percent adhesion of unstimulated cells is between 5 - 10%; base adhesion notably above this range indicates a problematic experiment and suggests the start population of T cells were nonspecifically pre-activated in preparation. Fold increase ...

Dyskusje

In order to properly analyze T cell adhesion, the stimulant to be included in the study must be considered when choosing an in vitro method. While there are several assays to study signals leading to LFA-1 activation and ICAM-1 binding all methods are not interchangeable. A static adhesion assay¹⁰ is best suited to study T cell-APC interactions; alternatively, the shear stress method detailed here is ideal to model T cell-epithelial cell interactions. In vivo, as chemokines are presented alon...

Materiały

Name	Company	Catalog Number	Comments
T cell samples (cell line or primary)	ATCC	TIB-152	Peripheral human T cells
CHO-ICAM-1 cells	ATCC	CRL-2093
µ-Slide VI 0.4 ibiTreat	ibidi	80606
500 ml glass bottle	Fisher	FB800500
250 ml glass bottle	Fisher	FB800250
Silicone tubing 0.8 mm	ibidi	10841
Confocal microscope with incubator chamber	Ziess	700	Any wide field fluorescent microscope
Syringe pump	New Era Pump Systems	NE-300
60 ml syringe	BD	309653
CFSE	eBioscience	65-0850
SDF-1α	R&D	350-NS-010/CF
RPMI	Lonza	12-702F/12
PBS	Lonza	17-516F
Microcentrifuge	Eppendorf	5424
D-Glucose	Sigma Aldrich	G8270
PMA	Sigma Aldrich	16561-29-8
Volocity software	Perkin Elmer	Version 6.2.1
ImageJ software	NIH	Version 1.48V
Tissue-culture treated culture dishes	Falcon	353003
Trypsin-EDTA (0.25%) Phenol Red	Gibco	25200114
Heat Inactivated FBS	Denville	FB5001-H
Penicillin/Streptomycin	Fisher	BP295950